JP2021516966A5 - - Google Patents
Info
- Publication number
- JP2021516966A5 JP2021516966A5 JP2020546981A JP2020546981A JP2021516966A5 JP 2021516966 A5 JP2021516966 A5 JP 2021516966A5 JP 2020546981 A JP2020546981 A JP 2020546981A JP 2020546981 A JP2020546981 A JP 2020546981A JP 2021516966 A5 JP2021516966 A5 JP 2021516966A5
- Authority
- JP
- Japan
- Prior art keywords
- anchor domain
- fusion protein
- binding
- seq
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862640859P | 2018-03-09 | 2018-03-09 | |
| US62/640,859 | 2018-03-09 | ||
| PCT/US2019/021639 WO2019173829A1 (en) | 2018-03-09 | 2019-03-11 | Delivering biological drugs to tissues |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021516966A JP2021516966A (ja) | 2021-07-15 |
| JP2021516966A5 true JP2021516966A5 (https=) | 2022-03-18 |
Family
ID=67846359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020546981A Pending JP2021516966A (ja) | 2018-03-09 | 2019-03-11 | 組織への生物学的薬物の送達 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11529389B2 (https=) |
| EP (1) | EP3762429A4 (https=) |
| JP (1) | JP2021516966A (https=) |
| AU (1) | AU2019231307A1 (https=) |
| WO (1) | WO2019173829A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9579273B2 (en) * | 2011-12-14 | 2017-02-28 | The Kitasato Institute | Delivery of therapeutic agents by a collagen binding protein |
| JP6871948B2 (ja) | 2016-04-27 | 2021-05-19 | アッヴィ・インコーポレイテッド | 抗ｉｌ−１３抗体を使用する、ｉｌ−１３活性が有害である疾患の治療方法 |
| WO2018148573A1 (en) | 2017-02-10 | 2018-08-16 | The Board Of Trustees Of The University Of Arkansas | Collagen-binding agent compositions and methods of using the same |
| EP3927728A2 (en) | 2019-02-21 | 2021-12-29 | Xencor, Inc. | Untargeted and targeted il-10 fc-fusion proteins |
| LU101758B1 (en) * | 2020-04-28 | 2021-10-28 | Microsoft Technology Licensing Llc | Digital wallet as a relying party in a decentralized network |
| US12403179B2 (en) | 2021-02-18 | 2025-09-02 | The Board Of Trustees Of The University Of Arkansas | Release of growth factors at wound healing stages |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6387663B1 (en) | 1998-07-31 | 2002-05-14 | University Of Southern California | Targeting pharmaceutical agents to injured tissues |
| US20040224010A1 (en) | 2002-11-15 | 2004-11-11 | Optime Therapeutics, Inc. | Ophthalmic liposome compositions and uses thereof |
| US20050027110A1 (en) * | 2003-07-24 | 2005-02-03 | Michael Russell | Drug delivery in the nervous system |
| JP3885077B2 (ja) | 2004-03-26 | 2007-02-21 | 独立行政法人科学技術振興機構 | 三次元ディスプレイ |
| US9187517B2 (en) | 2006-11-13 | 2015-11-17 | The Brigham And Women's Hospital, Inc. | Methods of promoting cardiac repair using growth factors fused to heparin binding sequences |
| EP2242504B1 (en) | 2008-01-09 | 2021-07-14 | The Schepens Eye Research Institute, Inc. | Therapeutic compositions for treatment of ocular inflammatory disorders |
| KR20120063475A (ko) | 2009-07-29 | 2012-06-15 | 글락소 그룹 리미티드 | 항-ｔｇｆ-베타 수용체 타입 ⅱ 단일 도메인 항체 |
| WO2012082659A1 (en) * | 2010-12-13 | 2012-06-21 | Cress Jonathan H | Disposable dispenser drop diverter |
| CA2827443C (en) | 2011-02-15 | 2021-07-06 | Vaxiion Therapeutics, Inc. | Therapeutic compositions and methods for antibody and fc-containing targeting molecule-based targeted delivery of bioactive molecules by bacterial minicells |
| US9579273B2 (en) | 2011-12-14 | 2017-02-28 | The Kitasato Institute | Delivery of therapeutic agents by a collagen binding protein |
| EP2847368B1 (en) | 2012-05-11 | 2020-08-19 | Merck Sharp & Dohme Corp. | Surface anchored light chain bait antibody display system |
| CN104619727B (zh) | 2012-06-25 | 2019-04-05 | 布里格姆及妇女医院股份有限公司 | 靶向治疗 |
| WO2014089267A1 (en) * | 2012-12-05 | 2014-06-12 | Eleven Biotherapeutics, Inc. | Galectin-3 fusion proteins |
| US20150328044A1 (en) | 2012-12-19 | 2015-11-19 | Glaxo Group Limited | Guide Device For A Liquid Dispenser |
| RS61778B1 (sr) * | 2013-05-06 | 2021-06-30 | Scholar Rock Inc | Kompozicije i postupci za modulaciju faktora rasta |
| WO2014197485A1 (en) | 2013-06-03 | 2014-12-11 | Ansun Biopharma, Inc. | Anti-viral therapeutic for infection of the eye |
| US9416197B2 (en) * | 2013-11-01 | 2016-08-16 | Ibc Pharmaceuticals, Inc. | Bispecific antibodies that neutralize both TNF-α and IL-6: novel therapeutic agent for autoimmune disease |
| TWI632160B (zh) * | 2015-01-16 | 2018-08-11 | 中央研究院 | 具有標的部分及效應部分的分子構建體 |
| BR112017023692A2 (pt) | 2015-05-01 | 2018-07-17 | The Regents Of The University Of California | moléculas imunoterapêuticas glican-dependentes |
| WO2018057522A1 (en) | 2016-09-20 | 2018-03-29 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Harnessing protein-based drugs comprising an anchor domain for use on the ocular surface |
-
2019
- 2019-03-11 JP JP2020546981A patent/JP2021516966A/ja active Pending
- 2019-03-11 WO PCT/US2019/021639 patent/WO2019173829A1/en not_active Ceased
- 2019-03-11 AU AU2019231307A patent/AU2019231307A1/en not_active Abandoned
- 2019-03-11 US US16/979,143 patent/US11529389B2/en active Active
- 2019-03-11 EP EP19763843.0A patent/EP3762429A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021516966A5 (https=) | ||
| US7582288B2 (en) | Methods of targeting multiple cytokines | |
| US8404814B2 (en) | Anti-EDB antibody-targeted IL-10 cytokine for therapy of rheumatoid arthritis | |
| CN103201284B (zh) | 用于癌症和慢性感染的治疗的具有激动剂活性的衍生自il-2的多肽 | |
| Strober et al. | The interleukins | |
| CN103079586B (zh) | G‑csf二聚体在治疗嗜中性粒细胞减少症中的应用 | |
| JP2020501510A5 (https=) | ||
| JP2021533204A5 (https=) | ||
| JP2022521428A5 (https=) | ||
| US10703799B2 (en) | IL-33R and IL-1RAcP fusion proteins | |
| Frieri | Corticosteroid effects on cytokines and chemokines | |
| TW570801B (en) | Osteoclastgenic inhibitory agent | |
| CN112135623B (zh) | 与疾病的治疗有关的组合物和方法 | |
| Wanebo | Tumor necrosis factors | |
| Kolls et al. | Recombinant cytokines and pulmonary host defense | |
| Bendtzen et al. | Naturally occurring autoantibodies to interleukin-1α, interleukin-6, interleukin-10, and interferon-α | |
| Fujisawa et al. | A synthetic peptide inhibitor for α-chemokines inhibits the tumour growth and pulmonary metastasis of human melanoma cells in nude mice | |
| Tamatani et al. | Existence of both IL-1 alpha and beta in normal human amniotic fluid: unique high molecular weight form of IL-1 beta | |
| EP4377452A2 (en) | Ace2 fusion proteins and uses thereof | |
| AU637909B2 (en) | Medical uses of m-csf | |
| US20260028397A1 (en) | Methods of treating ankylosing spondylitis | |
| Saiki et al. | Antimetastatic effect of endogenous tumor necrosis factor induced by the treatment of recombinant interferon γ followed by an analogue (GLA-60) to synthetic lipid A subunit | |
| CN106349393B (zh) | 一种增强抗体药物稳定性的结构 | |
| Lindley | Interleukin-8 | |
| WO2023196916A1 (en) | Methods of treating of hidradenitis suppurativa |